Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease

Más betegség

• Brain disease other than Parkinson's disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.).
• Dementia as defined by a MOCA score lower than 24/30
• Presence of major ongoing psychiatric illness such as acute non-controlled psychosis
• Poor general health (e.g. non-controlled diabetes, uncontrolled arterial hypertension, therapy for malignancy)
• Inability to follow the procedures of the study, e.g. filling out patient questionnaires due to language problems, psychological disorders, dementia, etc. of the participant

Egyéb

• Weight > 150kg
• Depression with acute suicidal ideation
• Participation in another interventional trial within the 30 days preceding and during the present study
• Participants with PSQI score lower or equal 5

• Informed Consent signed by the subject
• PD according to the MDS clinical diagnostic criteria for Parkinson's disease
• Suffering from reduced sleep quality as defined by pathological cut-off (score of > 5) on the Pittsburgh Sleep Quality Index (PSQI)
• Patients with stable antiparkinsonian, antidepressant, and sleep medications for six weeks before intervention and maintained on stable medication during the intervention period
• Treatment without bilateral deep brain stimulation
• Fluent in German